April Jones
About April Jones
April Jones is an Executive Cell Therapy Account Specialist with over 20 years of experience in the pharmaceutical and biotechnology industry, currently working at Kite Pharma. She specializes in educating community oncology accounts on cell therapy treatments and has previously held roles at Gilead Sciences and Organon Pharmaceuticals.
Work at Kite Pharma
April Jones currently serves as an Executive Cell Therapy Account Specialist at Kite Pharma, a position she has held since 2020. In this role, she focuses on educating community oncology accounts about cell therapy treatments. Her expertise in cell therapy is supported by over 20 years of experience in the pharmaceutical and biotechnology sectors. Based in Birmingham, Alabama, she is dedicated to advancing the understanding and application of innovative therapies within the oncology community.
Transition from Gilead Sciences to Kite Pharma
Before joining Kite Pharma, April Jones worked at Gilead Sciences for six years as an Executive Therapeutic Specialist, following a four-year tenure as an Executive Institutional Specialist. Her transition to Kite Pharma allowed her to leverage her extensive background in therapeutic and institutional specialization, further enhancing her capabilities in the field of cell therapy.
Education and Expertise
April Jones studied at Auburn University, where she earned a Bachelor of Arts (B.A.) degree in Communication and Media Studies from 1993 to 1997. This educational background has contributed to her effective communication skills in her current role, where she educates healthcare professionals about complex cell therapy treatments.
Background in Pharmaceuticals
April Jones has a robust background in the pharmaceutical industry, having worked for various companies over two decades. Prior to her roles at Gilead Sciences, she was employed at Organon Pharmaceuticals as a Territory Specialist from 2001 to 2006. Her diverse experiences across different companies have equipped her with a comprehensive understanding of therapeutic and institutional dynamics within the healthcare sector.